COVID-19 and thromboembolic disease
Friday, July 9, 2021
12. COVID-19, 1-hour Oral Session
•
S56
•
8:30 AM
>
9:30 AM
•
COVID-19 and thromboembolic disease
•
12. COVID-19
8:30 AM
•
3161
•
Thrombosis pathways in COVID-19 versus influenza-associated acute respiratory distress syndrome (ARDS): a targeted proteomics approach
>
E.
Emma
RADEMAKER (Utrecht)
8:40 AM
•
2857
•
Venous thromboembolic disease and D-dimer in non-critically ill patients with COVID-19 pneumonia
>
J.
Júlia
SELLARÈS-NADAL (Barcelona)
8:50 AM
•
989
•
Increased incidence of secondary infections in COVID-19 patients with thrombotic complications
>
M.
Marco
RIPA (Milano)
9:00 AM
•
1038
•
Early treatment with low-molecular-weight heparin reduces mortality rate of SARS-CoV-2 patients
>
A.
Andrea
DE VITO (Sassari)
9:10 AM
•
INT16
•
Q&A/Discussion
|